{
  "id": 3718,
  "text": "1724.Arseneau, J., Blessing, J.A., Stehman, F.B.& McGehee, R.A phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study).Invest New Drugs 4, 187-191 (1986).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 1724.Arseneau, J., Blessing, J.A., Stehman, F.B.& McGehee, R.A phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study).Invest New Drugs 4, 187-191 (1986).\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "卡铂在晚期鳞状细胞宫颈癌的治疗中具有一定的有效性。研究显示，卡铂作为一种铂类化疗药物，在针对鳞状细胞宫颈癌的应用中通常表现为耐受性较好，并在特定患者群体中能够减缓疾病进展。然而，与传统的顺铂相比，卡铂的疗效可能略低，但它具有更低的肾毒性和神经毒性。因此，对于无法耐受顺铂的患者，卡铂是一种重要的替代选择。最终疗效仍取决于患者个体的疾病特点以及联合治疗方案的组合。",
  "query": "**text中的内容与宫颈癌相关，这里是问题：**\n\n在晚期鳞状细胞宫颈癌的治疗中，卡铂作为一种化疗药物的有效性如何？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: **text中的内容与宫颈癌相关，这里是问题：**\n\n在晚期鳞状细胞宫颈癌的治疗中，卡铂作为一种化疗药物的有效性如何？\n\n<reference text>: 1724.Arseneau, J., Blessing, J.A., Stehman, F.B.& McGehee, R.A phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study).Invest New Drugs 4, 187-191 (1986).\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "卡铂在晚期鳞状细胞宫颈癌的治疗中具有一定的有效性。研究显示，卡铂作为一种铂类化疗药物，在针对鳞状细胞宫颈癌的应用中通常表现为耐受性较好，并在特定患者群体中能够减缓疾病进展。然而，与传统的顺铂相比，卡铂的疗效可能略低，但它具有更低的肾毒性和神经毒性。因此，对于无法耐受顺铂的患者，卡铂是一种重要的替代选择。最终疗效仍取决于患者个体的疾病特点以及联合治疗方案的组合。"
}